PubRank

Norio Yoshimura

Author PubWeight™ 28.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004 1.93
2 Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant. J Rheumatol 2007 1.50
3 FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study. Transplantation 2007 1.21
4 Short- and long-term donor outcomes after kidney donation: analysis of 601 cases over a 35-year period at Japanese single center. Transplantation 2009 1.20
5 Management and outcome of living kidney grafts with multiple arteries. Surg Today 2005 0.96
6 Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int 2006 0.95
7 Telmisartan inhibits human urological cancer cell growth through early apoptosis. Exp Ther Med 2010 0.92
8 Endoscopic resection for the diagnosis of visceral Kaposi's sarcoma. J Gastroenterol 2005 0.92
9 ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation. J Orthop Sci 2007 0.92
10 Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis. Eur J Immunol 2010 0.90
11 Combination analysis of three polymorphisms for predicting the risk for steroid-induced osteonecrosis of the femoral head. J Orthop Sci 2008 0.89
12 Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan. Transplantation 2003 0.87
13 Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. Acta Orthop 2008 0.86
14 Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer. Breast Cancer 2009 0.85
15 Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation 2003 0.84
16 Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation. Clin Transplant 2010 0.83
17 Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results. Transplant Res 2013 0.82
18 Histopathologic evaluation of living kidney donor candidates by pre-operative kidney biopsy. Clin Transplant 2009 0.81
19 Uncommon lymphoepithelial cyst with sebaceous glands of the pancreas. JOP 2013 0.80
20 TGF-β Signaling Regulates Pancreatic β-Cell Proliferation through Control of Cell Cycle Regulator p27 Expression. Acta Histochem Cytochem 2013 0.80
21 The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center. Transplantation 2010 0.80
22 Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients. J Pharm Pharmacol 2006 0.80
23 Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation. Clin Transplant 2009 0.80
24 Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan. World J Surg 2005 0.80
25 Percutaneous transcatheter thrombolysis for graft thrombosis after pancreas transplantation. Pancreas 2009 0.78
26 Appearance of LFA-1 in the initial stage of synaptogenesis of developing hippocampal neurons. Arch Histol Cytol 2008 0.78
27 Long-term outcome of kidney transplant using non-heart-beating donor: multicenter analysis of factors affecting graft survival. Clin Transplant 2003 0.78
28 Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010. Int J Med Sci 2013 0.78
29 [Indication and current issues in liver transplantation for hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2004 0.77
30 Successful treatment of invasive pulmonary aspergillosis after ABO-incompatible living donor liver transplantation under rapid steroid withdrawal protocol. Transplantation 2007 0.77
31 Clinicopathological evaluation of renal allograft treated with anti-CD25 monoclonal antibody. Clin Transplant 2005 0.75
32 A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation. Clin Transplant 2011 0.75
33 A case of successful kidney transplantation after an extremely long-term maintenance haemodialysis of 38 years. NDT Plus 2009 0.75
34 Clinicopathological evaluation of renal allografts of four patients by 20-year protocol biopsies. Clin Transplant 2003 0.75
35 Unusual biliary collaterals inside a transplanted liver. Transpl Int 2009 0.75
36 Expression of sphingosine-1 phosphate receptor in rat renal ischemia-reperfusion injury. Mol Med Rep 2011 0.75
37 Overlapped glomerular lesions of chronic rejection and recurrent lupus nephritis in transplanted kidney: a case report. Clin Transplant 2011 0.75
38 A rare case of functional pancreas graft with newly developed collateral venous drainage after complete portal thrombosis. Transpl Int 2009 0.75
39 The role of tissue factor in renal ischemic reperfusion injury of the rat. J Surg Res 2002 0.75
40 Pulmonary embolism in a living-related kidney transplantation donor. Surg Today 2003 0.75
41 Cysteinyl-leukotriene1 receptor antagonist prevents urological cancer cell growth through early apoptosis. Mol Med Rep 2011 0.75
42 Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure. Drug Metab Lett 2009 0.75
43 Clinical pharmacokinetics of mycophenolate mofetil in Japanese renal transplant recipients: A retrospective cohort study in a single center. Biol Pharm Bull 2006 0.75
44 Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era. Clin Transplant 2006 0.75
45 Analysis of preexisting baseline kidney lesions revealed by biopsy in living kidney donors: relationship with clinical parameters at the time of donation. Clin Transplant 2010 0.75
46 Antisense oligonucleotide for tissue factor inhibits hepatic ischemic reperfusion injury. Biochem Biophys Res Commun 2002 0.75
47 Administration of the selective cyclooxygenase (COX)-2 inhibitor etodolac prolongs cardiac allograft survival in a mouse model. Mol Med Rep 2010 0.75
48 BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan. Int J Urol 2008 0.75
49 Outcome of tonsillectomy for recurrent IgA nephropathy after kidney transplantation. Clin Transplant 2013 0.75
50 A case of living-related renal transplant from the donor with membranous nephropathy. Clin Transplant 2009 0.75